Increasing HAART-Induced Immune Restoration With Cyclosporine
Public ClinicalTrials.gov record NCT00031070. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Augmenting the Magnitude of HAART-Induced Immune Restoration With the Use of Cyclosporine
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to see if cyclosporine, taken when a patient begins highly active antiretroviral therapy (HAART), increases the number of CD4 T-cells (blood cells that fight infection) in a patient's blood. This study also will explore the safety of briefly giving cyclosporine to patients starting HAART.
Study identification
- NCT ID
- NCT00031070
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 40 participants
Conditions and interventions
Conditions
Interventions
- Abacavir sulfate, Lamivudine and Zidovudine Drug
- Cyclosporine Drug
- Hepatitis A Vaccine (Inactivated) Biological
- Efavirenz Drug
- Pneumococcal Conjugate Vaccine, Heptavalent Biological
- Rabies Vaccine Biological
Drug · Biological
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Not listed
- Primary completion
- Not listed
- Completion
- Dec 2006 (Actual)
- Last update posted
- Mar 9, 2015
Ends 2006
United States locations
- U.S. sites
- 15
- U.S. states
- 11
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of California , Davis Medical Center | Sacramento | California | 95814 | — |
| University of Miami | Miami | Florida | 33136-1013 | — |
| Rush Presbyterian - Saint Luke's Med Ctr / Infect Dis | Chicago | Illinois | 606123832 | — |
| Rush Presbyterian - Saint Luke's Med Ctr | Chicago | Illinois | 60612 | — |
| Indiana University Hospital | Indianapolis | Indiana | 46202-5250 | — |
| University of Maryland, Institute of Human Virology | Baltimore | Maryland | 21201 | — |
| Univ of Minnesota | Minneapolis | Minnesota | 55455-0392 | — |
| Washington Univ (St. Louis) | St Louis | Missouri | 63108 | — |
| Univ of North Carolina | Chapel Hill | North Carolina | 27599-7215 | — |
| Univ of North Carolina / Infectious Disease Division | Chapel Hill | North Carolina | 27599 | — |
| Case Western Reserve Univ | Cleveland | Ohio | 44106 | — |
| MetroHealth Med Ctr | Cleveland | Ohio | 441091998 | — |
| University of Pennsylvania, Philadelphia | Philadelphia | Pennsylvania | 19104 | — |
| Univ of Texas Southwestern Med Ctr | Dallas | Texas | 75390 | — |
| Univ of Texas, Southwestern Med Ctr of Dallas | Dallas | Texas | 75390 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00031070, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 9, 2015 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00031070 live on ClinicalTrials.gov.